APA (7th ed.) Citation

Derigs, P., Schubert, M., Dreger, P., Schmitt, A., Yousefian, S., Haas, S., . . . Schmitt, M. (2024). Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: A phase 1/2 study. Leukemia, 38(11), . https://doi.org/10.1038/s41375-024-02392-7

Chicago Style (17th ed.) Citation

Derigs, Patrick, et al. "Third-generation Anti-CD19 CAR T Cells for Relapsed/refractory Chronic Lymphocytic Leukemia: A Phase 1/2 Study." Leukemia 38, no. 11 (2024). https://doi.org/10.1038/s41375-024-02392-7.

MLA (9th ed.) Citation

Derigs, Patrick, et al. "Third-generation Anti-CD19 CAR T Cells for Relapsed/refractory Chronic Lymphocytic Leukemia: A Phase 1/2 Study." Leukemia, vol. 38, no. 11, 2024, https://doi.org/10.1038/s41375-024-02392-7.